Not yet recruiting
Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia
NCT06702098
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Guangzhou Ruixin Biotechnology Co., Ltd Guangzhou, Guangdong Province, China, China